Pharmacological treatment of depression in women with breast cancer: a systematic review Lærke Toftegård AndersenMelissa Voigt HansenIsmail Gögenur Review 28 September 2013 Pages: 325 - 330
Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis April A. N. RoseChristine ElserPamela J. Goodwin Review 09 October 2013 Pages: 331 - 339
DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA Md Mizanur RahmanJyothi Maria VeigasGabriel Fernandes Preclinical Study 24 September 2013 Pages: 341 - 352
Analysis of phyllodes tumor recurrence according to the histologic grade Sewha KimJi-Ye KimJa Seung Koo Preclinical Study 24 September 2013 Pages: 353 - 363
The expression of redox proteins in phyllodes tumor Sewha KimDo Hee KimJa Seung Koo Preclinical study 26 September 2013 Pages: 365 - 374
Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer Kyle R. CovingtonLauren BruscoSuzanne A. W. Fuqua Preclinical Study 28 September 2013 Pages: 375 - 384
Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents Ingar SeemannJohannes A. M. te PoeleFiona A. Stewart Preclinical study Open access 04 October 2013 Pages: 385 - 395
AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53 Ondrej KalousDylan ConklinRichard S. Finn Preclinical Study 05 October 2013 Pages: 397 - 408
The molecular diversity of Luminal A breast tumors Giovanni CirielloRileen SinhaNikolaus Schultz Preclinical study Open access 06 October 2013 Pages: 409 - 420
Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice Kathryn J. RuddyStephen D. DesantisHarold J. Burstein Clinical Trial 24 September 2013 Pages: 421 - 427
Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma Eleni AndreopoulouIvette S. VigodaJoseph A. Sparano Clinical Trial 26 September 2013 Pages: 429 - 435
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy Sara A. HurvitzFlorence DalencFabrice André Clinical trial Open access 08 October 2013 Pages: 437 - 446
Genetic variants in microRNAs and breast cancer risk in African American and European American women Song YaoKelly GrahamHua Zhao Epidemiology 24 September 2013 Pages: 447 - 459
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer Hope S. RugoAdam M. BrufskyDenise A. Yardley Epidemiology Open access 24 September 2013 Pages: 461 - 470
Clinical characteristics of breast cancer in patients with an NBS1 mutation T. HuzarskiC. CybulskiThe Polish Breast Cancer Consortium Epidemiology 27 September 2013 Pages: 471 - 476
Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers Jun Sang LeeSeho ParkByeong-Woo Park Epidemiology 27 September 2013 Pages: 477 - 484
Post-surgical highly sensitive C-reactive protein and prognosis in early-stage breast cancer Ariadna TibauMarguerite EnnisPamela J. Goodwin Epidemiology 27 September 2013 Pages: 485 - 493
Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women’s health initiative S. Wassertheil-SmollerA. P. McGinnC. Thomson Epidemiology 09 October 2013 Pages: 495 - 505
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome Dorien J. A. LobbezooRoel J. W. van KampenVivianne C. G. Tjan-Heijnen Epidemiology 09 October 2013 Pages: 507 - 514
Identification of two novel BRCA1-partner genes in the DNA double-strand break repair pathway Chiara GuglielmiIacopo CerriMaria Adelaide Caligo Brief Report 09 October 2013 Pages: 515 - 522